| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $967,898 | 5 | 100 |
| TETRAULT LYNN A. | director | 0 | $0 | 2 | $118,824 | $-118,824 |
| Olivo Alicia C | EVP, GC & Business Development | 0 | $0 | 1 | $250,992 | $-250,992 |
| Stone Warren | Pres & Chief Operating Officer | 0 | $0 | 1 | $276,682 | $-276,682 |
| Aunan Greg D | Chief Accounting Officer | 0 | $0 | 1 | $321,400 | $-321,400 |
NeoGenomics, Inc. specializes in providing cancer-focused diagnostic and testing services through an extensive network of laboratories located across the United States, Europe, and Asia. The company operates through two distinct divisions: Clinical Services and Pharma Services. Its comprehensive offerings cater to a diverse clientele, including hospitals, reference laboratories, pathologists, oncologists, clinicians, pharmaceutical companies, and researchers. NeoGenomics' advanced testing capabilities encompass cytogenetics, which examines …
Over the last 12 months, insiders at NeoGenomics, Inc. have bought $0 and sold $967,898 worth of NeoGenomics, Inc. stock.
On average, over the past 5 years, insiders at NeoGenomics, Inc. have bought $659,140 and sold $1.5M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 17,900 shares for transaction amount of $99,954 was made by Zook Anthony P. (Chief Executive Officer) on 2025‑08‑06.
| 2026-08-04 | Sale | Aunan Greg D | Chief Accounting Officer | 20,000 0.0768% | $16.07 | $321,400 | +5.95% | |
| 2026-06-15 | Sale | TETRAULT LYNN A. | director | 5,307 0.0204% | $11.10 | $58,908 | +48.76% | |
| 2026-06-09 | Sale | TETRAULT LYNN A. | director | 5,307 0.0201% | $11.29 | $59,916 | +43.53% | |
| 2026-01-20 | Sale | Stone Warren | Pres & Chief Operating Officer | 22,128 0.0846% | $12.50 | $276,682 | -1.90% | |
| 2025-11-25 | Sale | Olivo Alicia C | EVP, GC & Business Development | 20,916 0.0856% | $12.00 | $250,992 | -0.89% | |
| 2025-08-06 | Sherman Jeffrey Scott | Chief Financial Officer | 20,000 0.0774% | $5.62 | $112,322 | +84.34% | ||
| 2025-08-06 | Zook Anthony P. | Chief Executive Officer | 17,900 0.0688% | $5.58 | $99,954 | +84.34% | ||
| 2025-05-27 | Kelly Michael Aaron | director | 5,000 0.0197% | $7.60 | $38,000 | +16.27% | ||
| 2025-05-12 | Stone Warren | Pres & Chief Operating Officer | 5,700 0.0223% | $8.58 | $48,895 | +0.59% | ||
| 2025-05-09 | TETRAULT LYNN A. | director | 7,000 0.0275% | $8.14 | $56,974 | +6.02% | ||
| 2025-05-07 | KANOVSKY STEPHEN M | director | 4,000 0.0151% | $7.78 | $31,124 | +6.38% | ||
| 2025-05-06 | Zook Anthony P. | Chief Executive Officer | 18,900 0.0752% | $7.88 | $148,919 | +9.23% | ||
| 2025-05-05 | Gunn Neil | director | 4,510.31 0.0173% | $7.75 | $34,977 | +6.63% | ||
| 2025-05-05 | Perez David Brian | director | 10,000 0.0378% | $7.63 | $76,300 | +6.63% | ||
| 2025-05-02 | Sherman Jeffrey Scott | Chief Financial Officer | 20,000 0.0757% | $7.51 | $150,104 | +8.44% | ||
| 2024-11-15 | Sale | Olivo Alicia C | General Counsel | 5,175 0.0039% | $15.36 | $79,475 | -37.90% | |
| 2024-08-15 | Sale | Olivo Alicia C | General Counsel | 1,040 0.0008% | $16.05 | $16,695 | -21.37% | |
| 2024-05-15 | Sale | Olivo Alicia C | General Counsel | 1,049 0.0009% | $15.74 | $16,511 | -6.97% | |
| 2024-03-04 | Sale | TETRAULT LYNN A. | director | 6,112 0.0048% | $15.97 | $97,579 | -7.78% | |
| 2024-02-15 | Sale | Olivo Alicia C | General Counsel | 2,587 0.002% | $14.96 | $38,713 | +0.30% |
| Stone Warren | Pres & Chief Operating Officer | 121631 0.0934% | $2.05M | 1 | 1 | +0.59% |
| TETRAULT LYNN A. | director | 86115 0.0661% | $1.45M | 3 | 5 | +2.84% |
| KINDERHOOK, LP | 10 percent owner | 4848334 3.7234% | $81.6M | 5 | 0 | +67.12% |
| VAN OORT DOUGLAS M | Chairman and CEO | 2422790 1.8607% | $40.78M | 10 | 8 | +14.16% |
| Sherman Jeffrey Scott | Chief Financial Officer | 188332 0.1446% | $3.17M | 2 | 0 | +46.39% |
| CARDOZA GEORGE | President, Pharma Services | 176772 0.1358% | $2.98M | 2 | 12 | +53.16% |
| SHOVLIN ROBERT J. | President, Clinical Services | 150101 0.1153% | $2.53M | 1 | 11 | +4.86% |
| Mallon Mark | Chief Executive Officer | 72736 0.0559% | $1.22M | 1 | 0 | <0.0001% |
| ALBITAR MAHER | Chief Medical Officer | 60692 0.0466% | $1.02M | 1 | 5 | +25.36% |
| CROWTHER BRUCE K | director | 49564 0.0381% | $834,162.12 | 1 | 3 | <0.0001% |
| KANOVSKY STEPHEN M | director | 40090 0.0308% | $674,714.70 | 1 | 0 | +6.38% |
| HANNAH ALISON L. | director | 38782 0.0298% | $652,701.06 | 2 | 0 | +9.16% |
| Zook Anthony P. | Chief Executive Officer | 38066 0.0292% | $640,650.78 | 2 | 0 | +46.78% |
| Johnson Kevin C | director | 30983 0.0238% | $521,443.89 | 3 | 4 | +42.62% |
| Gunn Neil | director | 15846 0.0122% | $266,693.40 | 1 | 0 | +6.63% |
| Perez David Brian | director | 10000 0.0077% | $168,300.00 | 1 | 0 | +6.63% |
| Kelly Michael Aaron | director | 5000 0.0038% | $84,150.00 | 1 | 0 | +16.27% |
| Increased Positions | 121 | +39.54% | 22M | +16.94% |
| Decreased Positions | 127 | -41.5% | 20M | -15.25% |
| New Positions | 46 | New | 11M | New |
| Sold Out Positions | 33 | Sold Out | 8M | Sold Out |
| Total Postitions | 300 | -1.96% | 132M | +1.69% |
| Blackrock, Inc. | $226,955.00 | 14.96% | 19.3M | -125,659 | -0.65% | 2025-09-30 |
| Vanguard Group Inc | $163,508.00 | 10.78% | 13.9M | -227,026 | -1.61% | 2025-09-30 |
| First Light Asset Management, Llc | $116,745.00 | 7.7% | 9.93M | +3M | +45% | 2025-09-30 |
| Greenhouse Funds Lllp | $96,675.00 | 6.37% | 8.22M | +789,510 | +10.62% | 2025-09-30 |
| Millennium Management Llc | $70,262.00 | 4.63% | 5.97M | +3M | +80.13% | 2025-09-30 |
| State Street Corp | $59,062.00 | 3.89% | 5.02M | -88,883 | -1.74% | 2025-09-30 |
| Deerfield Management Company, L.P. | $52,301.00 | 3.45% | 4.45M | +2M | +107.05% | 2025-09-30 |
| Dimensional Fund Advisors Lp | $45,015.00 | 2.97% | 3.83M | -465,844 | -10.85% | 2025-09-30 |
| Schroder Investment Management Group | $40,948.00 | 2.7% | 3.48M | -240,870 | -6.47% | 2025-09-30 |
| D. E. Shaw & Co., Inc. | $38,777.00 | 2.56% | 3.3M | +2M | +252.6% | 2025-09-30 |